Clinical Research Directory

Anticoagulation in Patients With Venous Thromboembolism and Cancer

Sponsor: Pfizer

Summary

This study is a retrospective analysis of observational cohorts using data from prospectively collected administrative/claims data to investigate treatment patterns,healthcare resource utilisation (HCRU), direct and indirect costs (where feasible), and safety and effectiveness outcomes in patients with VTE and active cancer or patients with VTE and history of cancer who initiate anticoagulant treatment with a VKA, LMWH or NOACs.

Official title: VICTORIE (VTE In Cancer - Treatment, Outcomes and Resource Use In Europe)

Key Details

Conditions

Interventions

Locations (1)